InvestorsHub Logo
Post# of 253325
Next 10
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

Re: DewDiligence post# 41278

Tuesday, 01/30/2007 7:23:43 PM

Tuesday, January 30, 2007 7:23:43 PM

Post# of 253325
Serious. I don't think YMI is a 'quasi-legit scam company.'

Nimotuzumab has considerable promise, particularly given the recent demonstration that EGFRs are effective upfront for mCRC. Provided equivalent efficacy, nimo has the potential to completely supplant cetuximab because of the side-effect profile.

As always, I only care where YMI is going to be 6 mo to 1 y down the road. If I can get this at or near cash, then I'm in.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.